682 cases of Covid sub-variant JN.1 reported from 12 states till Jan 7

The number of cases of Covid-19 sub-variant JN.1 reported from 12 states till January 7 rose to 682

Coronavirus
Coronavirus
Press Trust of India New Delhi
2 min read Last Updated : Jan 08 2024 | 2:12 PM IST

The number of cases of COVID-19 sub-variant JN.1 reported from 12 states till January 7 rose to 682, official sources said on Monday.

They said 199 cases have been reported from Karnataka, 148 from Kerala, 139 from Maharashtra, 47 from Goa, 36 from Gujarat, 30 from Andhra Pradesh, 30 from Rajasthan, 26 from Tamil Nadu, 21 from Delhi, three from Odisha, two from Telangana and one from Haryana.

Even though the number of cases is rising and the JN.1 sub-variant has been detected in the country, there is no cause of immediate concern as the majority of those infected are opting for home-based treatment, indicating mild illness, officials said.

The Centre has asked the states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country.

States have been urged to ensure effective compliance with the detailed operational guidelines for revised surveillance strategy for COVID-19 shared by the Union Ministry of Health and Family Welfare.

They have asked to monitor and report district-wise cases of influenza-like illness and severe acute respiratory illness in all health facilities regularly for early detection of rising trend of cases.

The WHO has classified JN.1 as a separate "variant of interest" given its rapidly increasing spread but said it poses a "low" global public health risk.

The JN.1 sub-variant of the coronavirus was previously classified as a variant of interest (VOI) as part of the BA.2.86 sub-lineages, the parent lineage that is classified as a VOI, the world body said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus TestsCoronavirus VaccinecoronaHealth MinistryMansukh Lal Mandaviya

First Published: Jan 08 2024 | 2:12 PM IST

Next Story